Here's why one hedge fund manager is betting big on small-cap biotech firms.
- TheStreet.com•2 days ago
But it is all about timing, and so far there is no indication that this extended market is about to turn.
- Accesswire•2 days agoBull Market Ahead for the Biotech Industry in 2017? Today's Reports on Sarepta Therapeutics and Galectin Therapeutics
NEW YORK, NY / ACCESSWIRE / February 22, 2017 / The Biotech Industry's rally does not appear to be losing any steam in 2017. Both the iShares NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF ...
SRPT : Summary for Sarepta Therapeutics, Inc. - Yahoo Finance
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||30.91 x 100|
|Ask||30.93 x 100|
|Day's Range||29.70 - 31.56|
|52 Week Range||8.00 - 63.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.89|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|